Loading provider…
Loading provider…
Surgery Physician in Orange, CA
NPI: 1164539953Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
Regents of the University of California
health.ucsd.edu
HQ Phone
Get MD Victor's Phone Numberphone_androidMobile
Get MD Victor's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1997 - 2027

American Board of Surgery
Surgery

American Board of Surgery
Surgical Critical Care
UC Irvine Paul Merage School of Business
MBA • 2020 - 2022
2020 - 2022
University of Minnesota
Fellowship • Surgical Critical Care
2000 - 2001
Loma Linda University Health Education Consortium
Residency • Surgery
1995 - 2000
VCU School of Medicine
medschool.vcu.edu
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99212Established patient outpatient visit, total time 10-19 minutes | 17 | 21 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 16 | 48 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 36 |
American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps.
Authors: Jeffrey Litt, Damien Carter, Bruce Friedman, Rene Przkora, James Jeng
Publication Date: 2020-09-05
No Difference in Mortality and Outcomes After Addition of a Nearby Pediatric Trauma Center.
Authors: Jeffry Nahmias, Sebastian Schubl, Michael Lekawa, Matthew Dolich, Areg Grigorian
Journal: Pediatr Emerg Care
Publication Date: 2022-10-17
Review of machine learning for optical imaging of burn wound severity assessment.
Authors: Theresa Chin
Publication Date: 2024-02
Lead Sponsor: Mylan Inc.
Collaborators: Mylan Bertek Pharmaceuticals
Intervention / Treatment: DRUG: Topical Antimicrobial/Antifungal Medications, DRUG: Sulfamylon® For 5 % Topical Solution
Lead Sponsor: Stratatech, a Mallinckrodt Company
Intervention / Treatment: BIOLOGICAL: StrataGraft Skin Tissue, PROCEDURE: Autograft